Mediators of Inflammation / 2012 / Article / Tab 2

Clinical Study

Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy

Table 2

Changes in the lipid profile and blood pressure levels in 34 patients undergoing anti-TNF-alpha-adalimumab therapy due RA refractory to conventional DMARDs.

VariableDay 0Month 12Day 0 versus month 12

Total cholesterol (mg/dL)206.1±33.5208.2±40.70.94
LDL-cholesterol (mg/dL)125.4±4.8124.8±38.80.90
HDL-cholesterol (mg/dL)60.4±15.861.8±14.70.96
Atherogenic index3.61±1.033.51±0.980.73
Triglycerides (mg/dL)101.6±5.5108.7±4.10.31
Systolic blood pressure (mmHg)136.0±17.8126.9±18.20.10
Diastolic blood pressure (mmHg)81.6±9.679.2±11.60.36